Briefs: Autonomy signs up Bank of Thailand; Cyan new orders top $1m; Cambridge Uni spots genome sections tied to breast cancer
Autonomy Corporation plc, a leader in infrastructure software for the enterprise, said the Bank of Thailand has selected its Record Management solutions as an instrumental part of the Bank's business strategy to improve operational efficiency.
By implementing Autonomy Records Management across the organization, Bank of Thailand can ensure all documents and electronic files are managed in a secure and reliable environment as well as made available for seamless collaboration and retrieval. With Autonomy, Bank of Thailand became a forefront organization in the nation ready to take advantage provided by the Thai Electronic Transaction Act to improve its internal efficiency.
&
Cyan Holdings Plc, a fabless semiconductor company providing configurable application software and production ready modules based on feature rich, low power, microcontroller chips, said it has received orders for delivery in 2009 with a cumulative value in excess of $1m.
&
Two new regions of the human genome linked to breast cancer have been found by an international team of scientists led by University of Cambridge researchers; one increases the risk while the other reduces the risk of developing breast cancer.
This new study, published this week in Nature Genetics, identified one genetic region that reduces the risk of breast cancer by about 4% for women with one faulty copy and by 11% with two faulty copies. Mutations are normally associated with an increase in cancer risk but in some cases it can decrease the risk.
The second region was found to increase breast cancer risk by about 12 % in women who carry one faulty copy of the gene and by 23% if they carry two faulty copies.
Professor Doug Easton, lead author and director of Cancer Research UK's Genetic Epidemiology Unit at Cambridge University, said: "These two new genes bring us closer to developing a better test to identify women who are at a high risk of developing breast cancer, but there are still many more pieces of the puzzle to find."
